源语言 | 英语 |
---|---|
页(从-至) | e100-e111 |
期刊 | The Lancet Haematology |
卷 | 7 |
期 | 2 |
DOI | |
出版状态 | 已出版 - 2月 2020 |
!!!ASJC Scopus Subject Areas
- 血液学
指纹
探究 'Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial' 的科研主题。它们共同构成独一无二的指纹。引用此
Cell Therapy Transplant Canada (2020). Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. The Lancet Haematology, 7(2), e100-e111. https://doi.org/10.1016/S2352-3026(19)30220-0